KRAS and malignant colon neoplasm: Moreover, in an in vivo colon cancer model, they demonstrated a significant reduction in tumor growth for the animals treated with the micelles encapsulating the anti-KRAS antibody in comparison with the animals receiving the empty micelles (Figure 5) [87].